VNDD
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ
<Return to Disease List
Gangliosidosis Type 1 (GM1)​
  • Description
  • Signalment
  • Clinical Features
  • Neurolocalization
  • Genetics
<
>
Gangliosidosis (GM1) is a deficiency in the enzyme beta-galactosidase which causes defects in the catabolism of gangliosides resulting in their accumulation in neuron lysosomes.
Age of Onset: Less than 7 months of age
Sex Predisposition: Any sex of animal can be affected
Clinical Course:
​ Clinical signs worsen over time
Clinical Signs:
Behavioral/Mental Awareness 
Behavior changes
Hyperactivity

 
Movement 
Ataxia
Dysmetria
Hypermetria
Head tremor
Spastic paraplegia or tetraplegia

Cranial Nerves 
Visual impairment
Nystagmus

Other 
Death
Brain and spinal cord
 Autosomal recessive inheritance - Missense point mutation (G to A transition)​
To read more about this disease click below:
References
Picture
Contact us:
[email protected]

Privacy Policy
Terms and Conditions​
Disclaimer
  • Home
  • Search
  • Contact
  • More
    • Methodology
    • Video Library
    • External Resources
    • FAQ